Back
Regeneron Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
65
REGN
Regeneron Pharmaceuticals
Last Price:
1,138.97
Seasonality Move:
4.55%
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.13
Seasonality Move:
5.7%
Buy
65
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $1,146.75. The Score for REGN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $70.55. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $1,146.75
The current trend is moderately bearish and REGN is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $70.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.51 | Buy |
| Relative Strength Index (14 RSI): | 48.92 | Sell |
| Chaikin Money Flow: | 164221 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1149.07 - 1192.37) | Sell |
| Bollinger Bands (100): | (977.63 - 1141.67) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.98 | Sell |
| Relative Strength Index (14 RSI): | 20.79 | Sell |
| Chaikin Money Flow: | 1035913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (81.58 - 93.32) | Sell |
| Bollinger Bands (100): | (78.83 - 88.25) | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1146.52 | Buy |
| 20-day SMA: | 1170.06 | Sell |
| 50-day SMA: | 1125.49 | Buy |
| 200-day SMA: | 992.04 | Buy |
| 8-day EMA: | 1152.66 | Sell |
| 20-day EMA: | 1154.77 | Sell |
| 50-day EMA: | 1125.54 | Buy |
| 200-day EMA: | 1005.8 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.97 | Sell |
| 20-day SMA: | 86.7 | Sell |
| 50-day SMA: | 86.17 | Sell |
| 200-day SMA: | 87.12 | Sell |
| 8-day EMA: | 79.59 | Sell |
| 20-day EMA: | 84.09 | Sell |
| 50-day EMA: | 85.42 | Sell |
| 200-day EMA: | 86.31 | Sell |
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.99 per share, an increase next quarter of $1.60 per share, an increase this year of $2.56 per share, and an increase next year of $3.90 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Regeneron Pharmaceuticals Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||